A detailed history of Alliancebernstein L.P. transactions in Boston Scientific Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,814,710 shares of BSX stock, worth $151 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,814,710
Previous 1,797,891 0.94%
Holding current value
$151 Million
Previous $123 Million 13.49%
% of portfolio
0.05%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $1.13 Million - $1.31 Million
16,819 Added 0.94%
1,814,710 $140 Million
Q1 2024

May 14, 2024

SELL
$57.6 - $68.62 $9.62 Million - $11.5 Million
-167,041 Reduced 8.5%
1,797,891 $123 Million
Q4 2023

Feb 14, 2024

SELL
$48.64 - $57.81 $1.28 Million - $1.52 Million
-26,330 Reduced 1.32%
1,964,932 $114 Million
Q3 2023

Nov 14, 2023

SELL
$50.19 - $54.68 $4.74 Million - $5.17 Million
-94,519 Reduced 4.53%
1,991,262 $105 Million
Q2 2023

Aug 15, 2023

SELL
$49.72 - $54.64 $283,155 - $311,174
-5,695 Reduced 0.27%
2,085,781 $113 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $3.55 Million - $3.93 Million
-78,632 Reduced 3.62%
2,091,476 $105 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $6.9 Million - $8.23 Million
174,338 Added 8.74%
2,170,108 $100 Million
Q3 2022

Nov 15, 2022

BUY
$36.71 - $109.66 $9.43 Million - $28.2 Million
256,758 Added 14.76%
1,995,770 $77.3 Million
Q2 2022

Aug 15, 2022

SELL
$35.24 - $47.1 $416,642 - $556,863
-11,823 Reduced 0.68%
1,739,012 $64.8 Million
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $1.79 Million - $1.97 Million
43,695 Added 2.56%
1,750,835 $77.5 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $6.75 Million - $7.96 Million
-177,432 Reduced 9.41%
1,707,140 $72.5 Million
Q3 2021

Nov 10, 2021

BUY
$41.23 - $45.88 $3.45 Million - $3.83 Million
83,571 Added 4.64%
1,884,572 $81.8 Million
Q2 2021

Jul 30, 2021

SELL
$38.58 - $44.24 $10.9 Million - $12.4 Million
-281,324 Reduced 13.51%
1,801,001 $77 Million
Q1 2021

May 06, 2021

BUY
$35.27 - $39.67 $2.88 Million - $3.23 Million
81,544 Added 4.08%
2,082,325 $80.5 Million
Q4 2020

Feb 08, 2021

SELL
$33.15 - $41.97 $84.5 Million - $107 Million
-2,548,226 Reduced 56.02%
2,000,781 $71.9 Million
Q3 2020

Nov 12, 2020

SELL
$34.44 - $42.23 $13.9 Million - $17 Million
-403,176 Reduced 8.14%
4,549,007 $174 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $42.1 Million - $54.6 Million
-1,395,280 Reduced 21.98%
4,952,183 $174 Million
Q1 2020

May 14, 2020

SELL
$25.83 - $45.71 $11.7 Million - $20.6 Million
-451,623 Reduced 6.64%
6,347,463 $207 Million
Q4 2019

Feb 18, 2020

SELL
$37.87 - $45.37 $9.76 Million - $11.7 Million
-257,632 Reduced 3.65%
6,799,086 $307 Million
Q3 2019

Nov 14, 2019

SELL
$40.31 - $43.45 $15.9 Million - $17.1 Million
-393,372 Reduced 5.28%
7,056,718 $287 Million
Q2 2019

Aug 14, 2019

BUY
$34.91 - $42.98 $12.6 Million - $15.5 Million
361,494 Added 5.1%
7,450,090 $320 Million
Q1 2019

May 14, 2019

SELL
$32.91 - $40.75 $19.1 Million - $23.6 Million
-579,444 Reduced 7.56%
7,088,596 $272 Million
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $39.3 Million - $48.4 Million
1,238,771 Added 19.27%
7,668,040 $271 Million
Q3 2018

Nov 08, 2018

BUY
$32.83 - $38.63 $41.6 Million - $49 Million
1,268,172 Added 24.57%
6,429,269 $248 Million
Q2 2018

Aug 13, 2018

BUY
$26.84 - $34.32 $76.5 Million - $97.8 Million
2,849,915 Added 123.31%
5,161,097 $169 Million
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $2.13 Million - $2.41 Million
84,328 Added 3.79%
2,311,182 $63.1 Million
Q4 2017

Feb 13, 2018

SELL
$24.79 - $29.8 $1.31 Million - $1.58 Million
-53,043 Reduced 2.33%
2,226,854 $55.2 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $59.9 Million - $66.5 Million
2,279,897
2,279,897 $66.5 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $119B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.